Search

Author/Creator Furst, D E

2. A modified Delphi exercise to determine the extent of consensus with OMERACT outcome domains for studies of acute and chronic gout. Issue 6 (29th November 2007)

Authors:
Taylor, W J; Schumacher, H R; Baraf, H S B; Chapman, P; Stamp, L; Doherty, M; McQueen, F; Dalbeth, N; Schlesinger, N; Furst, D E; Mellado, J Vazquez; Becker, M A; Kavanaugh, A; Louthrenoo, W; Bardin, T; Khanna, D; Simon, L S; Yamanaka, H; Choi, H K; Zeng, X
Journal:
Annals of the rheumatic diseases
Issue:
Volume 67:Issue 6(2008)
Page Start:
888
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis. Issue 1 (8th July 2004)

Authors:
van Holten, J; Pavelka, K; Vencovsky, J; Stahl, H; Rozman, B; Genovese, M; Kivitz, A J; Alvaro, J; Nuki, G; Furst, D E; Herrero-Beaumont, G; McInnes, I B; Musikic, P; Tak, P P
Journal:
Annals of the rheumatic diseases
Issue:
Volume 64:Issue 1(2005)
Page Start:
64
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Certolizumab pegol in combination with dose-optimised methotrexate in DMARD-naïve patients with early, active rheumatoid arthritis with poor prognostic factors: 1-year results from C-EARLY, a randomised, double-blind, placebo-controlled phase III study. Issue 1 (10th May 2016)

Authors:
Emery, P; Bingham, C O; Burmester, G R; Bykerk, V P; Furst, D E; Mariette, X; van der Heijde, D; van Vollenhoven, R; Arendt, C; Mountian, I; Purcaru, O; Tatla, D; VanLunen, B; Weinblatt, M E
Journal:
Annals of the rheumatic diseases
Issue:
Volume 76:Issue 1(2017)
Page Start:
96
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Development of a provisional core set of response measures for clinical trials of systemic sclerosis. Issue 5 (24th September 2007)

Authors:
Khanna, D; Lovell, D J; Giannini, E; Clements, P J; Merkel, P A; Seibold, J R; Matucci-Cerinic, M; Denton, C P; Mayes, M D; Steen, V D; Varga, J; Furst, D E
Journal:
Annals of the rheumatic diseases
Issue:
Volume 67:Issue 5(2008)
Page Start:
703
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR). Issue 5 (15th January 2009)

Authors:
Kowal-Bielecka, O; Landewé, R; Avouac, J; Chwiesko, S; Miniati, I; Czirjak, L; Clements, P; Denton, C; Farge, D; Fligelstone, K; Földvari, I; Furst, D E; Müller-Ladner, U; Seibold, J; Silver, R M; Takehara, K; Toth, B Garay; Tyndall, A; Valentini, G; van den Hoogen, F
Journal:
Annals of the rheumatic diseases
Issue:
Volume 68:Issue 5(2009)
Page Start:
620
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. European League Against Rheumatism (EULAR) Scleroderma Trial and Research group (EUSTAR) recommendations for the treatment of systemic sclerosis: methods of elaboration and results of systematic literature research. Issue 5 (28th October 2008)

Authors:
Avouac, J; Kowal-Bielecka, O; Landewe, R; Chwiesko, S; Miniati, I; Czirjak, L; Clements, P; Denton, C; Farge, D; Fligelstone, K; Földvari, I; Furst, D E; Müller-Ladner, U; Seibold, J; Silver, R M; Takehara, K; Toth, B Garay; Tyndall, A; Valentini, G; van den Hoogen, F
Journal:
Annals of the rheumatic diseases
Issue:
Volume 68:Issue 5(2009)
Page Start:
629
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗